.jpg?format=webp&width=780)
This review focuses on Prostate cancer organoids and discusses engineering approaches to create more physiologically relevant models, enhancing their translational relevance for precision medicine. Three-dimensional (3D) organoid models have revolutionized preclinical cancer research by mimicking heterogeneity and allowing genetic and environmental manipulations. The goal is to unlock the transformative potential of precision medicine in Prostate cancer treatment.
Like
Save
Share